Four key opinion leaders (KOLs) in the field of stroke and a statistician to share their perspectives of the topline data from the TREASURE study conducted by the Company’s partner HEALIOS K.K. (Healios). The TREASURE study is a randomized, double-blind placebo-controlled study evaluating MultiStem administration for the treatment of ischemic stroke. The trial enrolled 206 patients and was conducted by 48 sites in Japan.
Register for the event in advance here: https://us06web.zoom.us/webinar/register/WN_oZVVGv_LTD-9J1ILDIzlmw